BTLA/CD272 Rekombinanter Antikörper
BTLA/CD272 Rekombinant Antikörper für FC, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
FC, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
241318H5
Kat-Nr. : 98096-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
98096-1-PBS bindet in FC, Indirect ELISA BTLA/CD272 und zeigt Reaktivität mit human
Getestete Reaktivität | human |
Wirt / Isotyp | Kaninchen / IgG |
Klonalität | Rekombinant |
Typ | Antikörper |
Immunogen | Rekombinantes Protein |
Vollständiger Name | B and T lymphocyte associated |
Berechnetes Molekulargewicht | 289 aa, 33 kDa |
GenBank-Zugangsnummer | BC107091 |
Gene symbol | BTLA |
Gene ID (NCBI) | 151888 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Protein A purfication |
Lagerungspuffer | PBS only |
Lagerungsbedingungen | Store at -80°C. |
Hintergrundinformationen
BTLA ( B and T lymphocyte attenuator), also known as CD272, is a member of the CD28 superfamily and is a type I membrane glycoprotein identified as an inhibitory receptor (PMID: 33859648). BTLA is extensively expressed in lymph nodes, thymus, and spleen, with little or no expression in organs such as the heart, kidney, brain, and liver (PMID: 33859648). Among immune cells, BTLA is primarily expressed in B and T cells, with higher expression in B cells compared to T cells in the mouse spleen (PMID: 33859648). BTLA plays a crucial role in regulating stimulatory and inhibitory signals in immune responses.